| |
| |
|
| Insider
Information: |
Cola Michael F |
| Relationship: |
Director |
| City: |
Wayne |
| State: |
PA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
385,290 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$181,301 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
385,290 |
|
|
| Total
Value |
$181,301 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
0
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
1.0
|
0.0
|
| Percentage
Gain/Loss : |
 29.8%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Aevi Genomic Medicine Inc |
GNMX |
Chief Executive Office... |
2020-06-09 |
175,746 |
2014-12-01 |
0 |
Premium* |
|
|
Vanda Pharmaceuticals Inc. |
VNDA |
Director |
2019-06-13 |
15,000 |
2017-06-15 |
0 |
Premium* |
|
|
Avalo Therapeutics, Inc |
AVTX |
Chief Executive Office... |
2020-06-09 |
175,746 |
2020-02-03 |
0 |
Premium* |
|
|
Phathom Pharmaceuticals, Inc. |
PHAT |
Director |
2023-05-25 |
18,798 |
2019-10-29 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
13 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PHAT |
Phathom Pharmaceuticals, ... |
Director |
– • – |
2023-05-25 |
4 |
A |
$0.00 |
$0 |
D/D |
9,000 |
18,798 |
0 |
- |
|
| GNMX |
Aevi Genomic Medicine Inc |
Chief Executive Officer |
• • – |
2020-06-09 |
4 |
B |
$2.50 |
$250,000 |
D/D |
100,000 |
175,746 |
2.81 |
- |
|
| AVTX |
Avalo Therapeutics, Inc |
Chief Executive Officer |
• • – |
2020-06-09 |
4 |
B |
$2.50 |
$250,000 |
D/D |
100,000 |
175,746 |
2.81 |
% |
|
| GNMX |
Aevi Genomic Medicine Inc |
President and CEO |
• • – |
2020-02-03 |
4 |
D |
$0.00 |
$0 |
D/D |
(2,267,859) |
0 |
0 |
- |
|
| AVTX |
Avalo Therapeutics, Inc |
Chief Executive Officer |
• • – |
2020-02-03 |
4 |
A |
$0.00 |
$0 |
D/D |
75,746 |
75,746 |
0 |
- |
|
| GNMX |
Aevi Genomic Medicine Inc |
President and CEO |
• • – |
2019-12-05 |
4 |
B |
$0.13 |
$274,616 |
D/D |
2,049,376 |
2,267,859 |
2.81 |
- |
|
| PHAT |
Phathom Pharmaceuticals, ... |
Director |
– • – |
2019-10-29 |
4 |
B |
$19.00 |
$186,162 |
D/D |
9,798 |
9,798 |
2.39 |
- |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
Director |
– • – |
2019-06-13 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
15,000 |
0 |
- |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
Director |
– • – |
2018-06-13 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
10,000 |
0 |
- |
|
| GNMX |
Aevi Genomic Medicine Inc |
President and CEO |
• • – |
2017-10-17 |
4 |
B |
$1.26 |
$149,999 |
D/D |
119,047 |
218,483 |
2.81 |
- |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
Director |
– • – |
2017-06-15 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
5,000 |
0 |
- |
|
| GNMX |
Aevi Genomic Medicine Inc |
President and CEO |
• • – |
2015-10-06 |
4 |
B |
$6.50 |
$249,990 |
D/D |
38,460 |
99,436 |
2.81 |
- |
|
| GNMX |
Aevi Genomic Medicine Inc |
President and CEO |
• • – |
2014-12-01 |
4 |
B |
$4.10 |
$250,002 |
D/D |
60,976 |
60,976 |
2.81 |
- |
|
13 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
